FibroGen, Inc. ( FGEN) - Key Metrics
Stock symbol FGEN is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker FGEN was renamed to
KYNB
effective 2026-01-08.
FGEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $0.33 | -$1.88 | $3.14 | $3.13 |
| 2025Q1 | $0.03 | $0.05 | $0.03 | $0.03 |
| 2024Q4 | -$1.22 | $0.18 | -$0.30 | -$0.30 |
| 2024Q3 | $0.46 | -$0.17 | -$0.08 | -$0.08 |
| 2024Q2 | $0.51 | -$0.16 | -$0.40 | -$0.40 |
FGEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | -0.70 |
| 2025Q1 | ? | 42.16 |
| 2024Q4 | ? | 18.56 |
| 2024Q3 | -13.05% | -14.69 |
| 2024Q2 | ? | -30.91 |
FGEN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q2 | 59.14% | ? |
| 2025Q1 | 0.35% | ? |
| 2024Q4 | -2.29% | ? |
| 2024Q3 | -0.84% | 5.55% |
| 2024Q2 | -2.08% | ? |
FGEN
Price: $9.71
52 week price:
Payout Ratio Range:
Earnings Per Share: -12.85 USD
P/E Ratio: -0.71
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Ebitda: -33.4 millionMarket Capitalization: 37.1 million